Amended surrogacy law likely to boost market potential, say experts

Written by
Arva Health Team
25 Feb 2024
Business Standard’s article discusses the recent amendment to the Surrogacy (Regulation) Act 2021. We believe that permitting the use of one donor gamete helps remove barriers for couples facing medical challenges. This regulatory shift not only increases market potential but also reinforces the need for accessible, innovative fertility solutions like ours. We’re encouraged by these changes and remain committed to providing comprehensive reproductive care.